Candida infections in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice
Authors:
- Saima AslamSASaima Aslam
- Coleman RotsteinCRColeman Rotstein
- the AST Infectious Disease Community of PracticeTPthe AST Infectious Disease Community of Practice
- 2 June 2019
- journal article
- research article
- Published by Wiley in Clinical Transplantation
- Vol. 33 (9) , e13623
Abstract
These updated guidelines from the American Society of Transplantation Infectious Diseases Community of Practice provide recommendations for the diagnosis and management of Candida infections in solid organ transplant recipients. Candida infections manifest primarily as candidemia and invasive candidiasis and cause considerable morbidity and mortality. Early diagnosis and initiation of treatment are necessary to reduce mortality. For both candidemia and invasive candidiasis, an echinocandin is recommended for initial therapy. However, early transition to oral therapy is encouraged when patients are stable and the organism is susceptible. Candida prophylaxis should be targeted for high‐risk patients in liver, small bowel, and pancreas transplant recipients. Future research should address which patient groups may benefit most from preventative antifungal therapy strategies.Keywords
This publication has 119 references indexed in Scilit:
- New Clonal Strain ofCandida auris, Delhi, IndiaEmerging Infectious Diseases, 2013
- Candida albicans White and Opaque Cells Undergo Distinct Programs of Filamentous GrowthPLOS Pathogens, 2013
- Multicenter Study of Posaconazole Therapeutic Drug Monitoring: Exposure-Response Relationship and Factors Affecting ConcentrationAntimicrobial Agents and Chemotherapy, 2012
- Prospective, Observational Study of Voriconazole Therapeutic Drug Monitoring among Lung Transplant Recipients Receiving Prophylaxis: Factors Impacting Levels of and Associations between Serum Troughs, Efficacy, and ToxicityAntimicrobial Agents and Chemotherapy, 2012
- Antibiotic Exposure as a Risk Factor for Fluconazole-Resistant Candida Bloodstream InfectionAntimicrobial Agents and Chemotherapy, 2012
- Comparison of In Vitro Susceptibility Characteristics of Candida Species from Cases of Invasive Candidiasis in Solid Organ and Stem Cell Transplant Recipients: Transplant-Associated Infections Surveillance Network (TRANSNET), 2001 to 2006Journal of Clinical Microbiology, 2011
- PCR Diagnosis of Invasive Candidiasis: Systematic Review and Meta-AnalysisJournal of Clinical Microbiology, 2011
- Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-Year Analysis of Susceptibilities of Candida Species to Fluconazole and Voriconazole as Determined by CLSI Standardized Disk DiffusionJournal of Clinical Microbiology, 2010
- Candida krusei , a Multidrug-Resistant Opportunistic Fungal Pathogen: Geographic and Temporal Trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005Journal of Clinical Microbiology, 2008
- Reactivity of (1→3)-β- d -Glucan Assay with Commonly Used Intravenous AntimicrobialsAntimicrobial Agents and Chemotherapy, 2006